Alzheimer's disease

hide

Alzheimer's disease (AD), also called Alzheimer disease, Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer's, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Generally it is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer's can occur much earlier. An estimated 26.6 million people worldwide had Alzheimer's in 2006; this number may quadruple by 2050.

Although each sufferer experiences Alzheimer's in a unique way, there are many common symptoms. The earliest observable symptoms are often mistakenly thought to be 'age-related' concerns, or manifestations of stress. In the early stages, the most commonly recognised symptom is memory loss, such as difficulty in remembering recently learned facts. When a doctor or physician has been notified, and AD is suspected, the diagnosis is usually confirmed with behavioural assessments and cognitive tests, often followed by a brain scan if available. As the disease advances, symptoms include confusion, irritability and aggression, mood swings, language breakdown, long-term memory loss, and the general withdrawal of the sufferer as their senses decline. Gradually, bodily functions are lost, ultimately leading to death. Individual prognosis is difficult to assess, as the duration of the disease varies. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years. The mean life expectancy following diagnosis is approximately seven years. Fewer than three percent of individuals live more than fourteen years after diagnosis.

The cause and progression of Alzheimer's disease are not well understood. Research indicates that the disease is associated with plaques and tangles in the brain. Currently used treatments offer a small symptomatic benefit; no treatments to delay or halt the progression of the disease are as yet available. As of 2008, more than 500 clinical trials were investigating possible treatments for AD, but it is unknown if any of them will prove successful. Many measures have been suggested for the prevention of Alzheimer's disease, but their value is unproven in slowing the course and reducing the severity of the disease. Mental stimulation, exercise, and a balanced diet are often recommended, as both a possible prevention and a sensible way of managing the disease.

Because AD cannot be cured and is degenerative, management of patients is essential. The role of the main caregiver is often taken by the spouse or a close relative. Alzheimer's disease is known for placing a great burden on caregivers; the pressures can be wide-ranging, involving social, psychological, physical, and economic elements of the caregiver's life. In developed countries, AD is one of the most economically costly diseases to society.

For more information about Alzheimer's disease, read the full article at Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.


News tagged with alzheimer's disease

results timeline


Popular Alzheimer's theory may be false trail

Medicine & Health / Research

created Jun 15, 2009 | popularity 5 / 5 (1) | comments 3

The idea that anti-inflammatory drugs might protect people struggling with dementia from Alzheimer's disease has received a blow with the online release of a study of human brain tissue in Acta Neuropathologica.


Structure of the NCS-1 protein

New insight into Alzheimer’s disease

Medicine & Health / Diseases

created Dec 24, 2008 | popularity 5 / 5 (4) | comments 1

(PhysOrg.com) -- A new molecule important in a part of the memory that allows recognition of people has been identified by researchers at the University of Bristol. This type of memory is impaired at an early ...


X-Rays for Early Alzheimer's Disease Detection

Medicine & Health / Research

created Jun 15, 2009 | popularity 5 / 5 (1) | comments 0

Researchers at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory have demonstrated a new, highly detailed x-ray imaging technique that could be developed into a method for early diagnosis of Alzheimer’s ...


Alzheimer's disease: Newly found peptide offers hope of early test and better treatment

Medicine & Health / Diseases

created Jun 10, 2009 | popularity not rated yet | comments 0

Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, ...


Scientists make strides toward defining genetic signature of Alzheimer's disease

Medicine & Health / Diseases

created Dec 31, 2008 | popularity 4.7 / 5 (3) | comments 0

Scientists have new information about the complex genetic signature associated with Alzheimer's disease, the leading cause of cognitive decline and dementia in the elderly. The research, published by Cell Press in the January ...


Cerebrospinal fluid shows Alzheimer's disease deterioration much earlier

Medicine & Health / Diseases

created Jun 18, 2009 | popularity not rated yet | comments 0

It is possible to determine which patients run a high risk of developing Alzheimer's disease and the dementia associated with it, even in patients with minimal memory impairment. This has been shown by recent research at ...


New technique opens door to early Alzheimer's diagnosis

Medicine & Health / Diseases

created Jun 16, 2009 | popularity not rated yet | comments 0

A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's ...


New data demonstrate potential for early detection of Alzheimer's disease

Medicine & Health / Diseases

created Jun 16, 2009 | popularity 5 / 5 (2) | comments 0

Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be ...


Depression may increase risk of Alzheimer's disease in people with memory problems

Medicine & Health / Diseases

created Jun 15, 2009 | popularity not rated yet | comments 0

People with memory problems who are depressed are more likely to develop Alzheimer's disease compared to people who are not depressed, according to a study published in the current issue of Neurology, the medical journal of the ...